Newer antibiotics

Bodey, 1971, Carbenicillin therapy for Pseudomonas infections, J.A.M.A., 218, 62, 10.1001/jama.1971.03190140038007 Cuneri, 1970, Intravenous administration of carbenicillin for septicemia due to Pseudomonas aeruginosa following thermal injury, J. Infect. Dis., 122, 540 Fullbrook, 1970, R-factor mediated β-lactamase in Pseudomonas aeruginosa, Nature, London, 226, 1054, 10.1038/2261054a0 Hoffman, 1970, Pharmacodynamics of carbenicillin in hepatic and renal failure, Ann. Int. Med., 73, 173, 10.7326/0003-4819-73-2-173 Huang, 1971, Carbenicillin in patients with cystic fibrosis: Clinical pharmacology and therapeutic evaluation, J. Pediat., 78, 338, 10.1016/S0022-3476(71)80026-4 Jordon, 1970, Carbenicillin in treatment of severe infections due to Pseudomonas, J. Infect. Dis., 122, 96, 10.1093/infdis/122.Supplement_1.S96 Marks, 1970, Carbenicillin—a clinical and laboratory evaluation, Ann. Int. Med., 73, 179, 10.7326/0003-4819-73-2-179 Neu, 1969, Carbenicillin: Clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections, Ann. Int. Med., 71, 903, 10.7326/0003-4819-71-5-903 Turck, 1970, The role of carbenicillin in treatment of infections of the urinary tract, J. Infect. Dis., 122, 29, 10.1093/infdis/122.Supplement_1.S29 Johnson, 1968, Cephaloglycin, J.A.M.A., 206, 2698, 10.1001/jama.1968.03150120032006 Matsen, 1971, Cephaloglycin in pediatric patients, Am. J. Dis. Child., 121, 38 Ronald, 1968, Cephaloglycin in infections of the urinary tract, Arch. Int. Med., 121, 39, 10.1001/archinte.1968.03640010041005 Cox, 1971, Cephalosporin therapy of urinary tract infections, Postgrad. M. J., 47, 107 Disney, 1971, Cephalexin and penicillin therapy of childhood betahemolytic streptococcal infections, Postgrad. Med., 47, 51 Duncan, 1971, Cephalosporin antibiotics in venereal disease, Postgrad. Med., 47, 119 Fass, 1970, Cephalexin—a new oral cephalosporin: Clinical evaluation in sixty-three patients, Am. J. M. Sc., 259, 187, 10.1097/00000441-197003000-00006 Griffith, 1970, Cephalexin, M. Clin. North America, 54, 1229, 10.1016/S0025-7125(16)32589-5 Kabins, 1970, Cephalexin therapy as related to renal function, Am. J. M. Sc., 259, 133, 10.1097/00000441-197002000-00007 Kirby, 1971, Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients, Postgrad. M. J., 47, 41 Levinson, 1969, Clinical and in vitro evaluation of cephalexin, J.A.M.A., 209, 133 Sales, 1972, Cephalexin levels in human bile in presence of biliary tract disease, Brit. M. J., 3, 441, 10.1136/bmj.3.5824.441 Bodey, 1971, Gentamicin therapy for infections in patients with cancer, J. Infect. Dis., 124, 174, 10.1093/infdis/124.Supplement_1.S174 Cutler, 1972, Correlation of serum creatinine concentration and gentamicin half-life, J.A.M.A., 219, 1037, 10.1001/jama.1972.03190340043010 Jackson, 1971, Ototoxicity of gentamicin in man, J. Infect. Dis., 124, 130, 10.1093/infdis/124.Supplement_1.S130 McCracken, 1971, Pharmacologic evaluation of gentamicin in newborn infants, J. Infect. Dis., 124, 214, 10.1093/infdis/124.Supplement_1.S214 Riff, 1971, Pharmacology of gentamicin in man, J. Infect. Dis., 124, 98, 10.1093/infdis/124.Supplement_1.S98 Duncan, 1972, Treatment of gonorrhea with spectinomycin hydrochloride: Comparison with standard penicillin schedules, Antimicrob. Agents & Chemotherap., 1, 210, 10.1128/AAC.1.3.210 Wagner, 1968, Absorption, distribution and elimination of spectinomycin hydrochloride in man, Internat. J. Clin. Pharmacol., 1, 261 Guttler, 1971, Effect of rifampin and minocycline on meningococcal carrier rates, J. Infect. Dis., 124, 199, 10.1093/infdis/124.2.199 Steigbigel, 1968, Susceptibility of common pathogenic bacteria to seven tetracyclines in vitro, Am. J. M. Sc., 255, 179, 10.1097/00000441-196803000-00005 Martin, 1972, In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens, Antimicrob. Agents & Chemotherap., 1, 148, 10.1128/AAC.1.2.148 McGehee, 1968, Comparative studies of the antibacterial activity in vitro and absorption and excretion of lincomycin and clindamycin, Am. J. M. Sc., 256, 279, 10.1097/00000441-196811000-00002 Oppenheimer, 1968, Laboratory and clinical evaluation of 7-chloro-7-deoxylincomycin, Am. J. M. Sc., 256, 314, 10.1097/00000441-196811000-00006 Acocella, 1972, Kinetics of rifampin and isoniazid administered alone and in combination to normal subjects and patients with liver disease, Gut, 13, 47, 10.1136/gut.13.1.47 Devine, 1970, Rifampin: Levels in serum and saliva and effect on the meningococcal carrier state, J.A.M.A., 214, 1055, 10.1001/jama.1970.03180060033006 D'Oliveira, 1972, Cerebrospinal fluid concentrations of rifampin in meningeal tuberculosis, Am. Rev. Resp. Dis., 106, 432, 10.1164/arrd.1972.106.3.432 Eickhoff, 1971, In vitro and in vivo studies of resistance to rifampin in meningococci, J. Infect. Dis., 123, 414, 10.1093/infdis/123.4.414 Furesz, 1970, Chemical and biological properties of rifampin, Antibiotics & Chemotherap., 16, 316, 10.1159/000386837 Vall-Spinosa, 1970, Rifampin in the treatment of drug-resistant Mycobacterium, tuberculosis infections, New England J. Med., 283, 616, 10.1056/NEJM197009172831202 Verbist, 1972, Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis, Chest, 61, 555, 10.1016/S0012-3692(15)39155-8 Wehrli, 1971, Actions of the rifamycins, Bact. Rev., 35, 290, 10.1128/br.35.3.290-309.1971